Bile acid signalling and its role in anxiety disorders

Bile acid signalling and its role in anxiety disorders

Anxiety disorder is a prevalent neuropsychiatric disorder that afflicts 7.3%~28.0% of the world’s population. Bile acids are synthesized by hepatocytes and modulate metabolism via farnesoid X receptor (FXR), G protein-coupled receptor (TGR5), etc. These effects are not limited to the gastrointestina...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Simin Chen, Qi Shao, Jiayi Chen, Xinyi Lv, Jing Ji, Yan Liu, Yuehan Song
Format:	Artikel
Sprache:	English
Veröffentlicht:	Frontiers Media S.A. 2023-11-01
Schriftenreihe:	Frontiers in Endocrinology
Schlagworte:	anxiety disorders bile acid signaling FXR TGR5 FGF19 GLP-1
Online Zugang:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1268865/full

Ähnliche Einträge

Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System
von: Kim L. Mertens, et al.
Veröffentlicht: (2017-11-01)

Physiological Role of Bile Acids Modified by the Gut Microbiome
von: Yoshimitsu Kiriyama, et al.
Veröffentlicht: (2021-12-01)

Cross-Talk Between Bile Acids and Gastro-Intestinal and Thermogenic Hormones: Clues from Bariatric Surgery
von: Gabriella Garruti, et al.
Veröffentlicht: (2017-11-01)

Bile Acids Induce Neurite Outgrowth in Nsc-34 Cells via TGR5 and a Distinct Transcriptional Profile
von: Hayley D. Ackerman, et al.
Veröffentlicht: (2023-01-01)

Bile acid signaling in skeletal muscle homeostasis: from molecular mechanisms to clinical applications
von: Feng Jia, et al.
Veröffentlicht: (2025-03-01)

Bile acid-mediated signaling in cholestatic liver diseases
von: Jing Zeng, et al.
Veröffentlicht: (2023-04-01)

Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
von: Róisín Ní Dhonnabháín, et al.
Veröffentlicht: (2021-11-01)

Roles of bile acids signaling in neuromodulation under physiological and pathological conditions
von: Chen Xing, et al.
Veröffentlicht: (2023-06-01)

Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
von: Meilin Wei, et al.
Veröffentlicht: (2024-06-01)

Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling
von: Qiaoling Wang, et al.
Veröffentlicht: (2023-12-01)

The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
von: Yoshimitsu Kiriyama, et al.
Veröffentlicht: (2019-06-01)

Bile acid receptors and renal regulation of water homeostasis
von: Yanlin Guo, et al.
Veröffentlicht: (2023-11-01)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
von: Rui Xue, et al.
Veröffentlicht: (2021-10-01)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
von: Justine Gillard, et al.
Veröffentlicht: (2022-01-01)

Improving glucose and lipids metabolism: drug development based on bile acid related targets
von: Hanchen Shen, et al.
Veröffentlicht: (2021-01-01)

Compound K attenuates hyperglycemia by enhancing glucagon-like peptide-1 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism
von: Fengyuan Tian, et al.
Veröffentlicht: (2022-11-01)

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
von: Geoffrey Porez, et al.
Veröffentlicht: (2012-09-01)

Bile Acid Metabolic Profiles and Their Correlation with Intestinal Epithelial Cell Proliferation and Barrier Integrity in Suckling Piglets
von: Min Zhu, et al.
Veröffentlicht: (2024-01-01)

Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (TGR5) signaling pathways improved the hepatic lipid metabolism in hybrid grouper
von: Jia Xu, et al.
Veröffentlicht: (2022-02-01)

Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5
von: Samuel A. J. Trammell, et al.
Veröffentlicht: (2020-05-01)

Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor
von: Yusuke Iguchi, et al.
Veröffentlicht: (2010-06-01)

Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity
von: Julia Münzker, et al.
Veröffentlicht: (2022-06-01)

Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
von: Lili Ding, et al.
Veröffentlicht: (2021-06-01)

Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress
von: Weijia Cai, et al.
Veröffentlicht: (2023-11-01)

Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
von: Bing Han, et al.
Veröffentlicht: (2023-12-01)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
von: Xin Ye, et al.
Veröffentlicht: (2022-10-01)

Bile Acid Physiology
von: Agostino Di Ciaula, et al.
Veröffentlicht: (2017-11-01)

Bile Acid Network and Vascular Calcification-Associated Diseases: Unraveling the Intricate Connections and Therapeutic Potential
von: Wang C, et al.
Veröffentlicht: (2023-10-01)

The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
von: Youchao Qi, et al.
Veröffentlicht: (2022-08-01)

Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways
von: Jiahua Wang, et al.
Veröffentlicht: (2024-08-01)

Bile acid receptors and signaling crosstalk in the liver, gut and brain
von: Jessica M. Ferrell, et al.
Veröffentlicht: (2021-09-01)

FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection
von: Ju-Hee Kang, et al.
Veröffentlicht: (2021-09-01)

TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload
von: Valeska Bidault-Jourdainne, et al.
Veröffentlicht: (2021-04-01)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis
von: Claudia D. Fuchs, et al.
Veröffentlicht: (2023-11-01)

From dried bear bile to molecular investigation of differential effects of bile acids in ex vivo and in vitro models of myocardial dysfunction: Relevance for neuroinflammation
von: Fei Huang, et al.
Veröffentlicht: (2023-10-01)

Mechanism of action of the bile acid receptor TGR5 in obesity
von: Weijun Lun, et al.
Veröffentlicht: (2024-02-01)

Intestinal Stearoyl-CoA Desaturase-1 Regulates Energy Balance via Alterations in Bile Acid HomeostasisSummary
von: Natalie Burchat, et al.
Veröffentlicht: (2024-01-01)

The bile acid receptor TGR5 inhibits platelet activation and thrombus formation
von: Friedrich Reusswig, et al.
Veröffentlicht: (2024-12-01)

Ji-Ni-De-Xie ameliorates type 2 diabetes mellitus by modulating the bile acids metabolism and FXR/FGF15 signaling pathway
von: Yiwen Tao, et al.
Veröffentlicht: (2024-05-01)

Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
von: Yixuan Qiu, et al.
Veröffentlicht: (2021-01-01)